Skip to content
Markets News
Global1 min read

India Extends 30% Margin Cap to 137 Cancer Drugs

Makkler Newsroom
October 23, 2026 · Based on reporting by The Guardian
Photo: Pöllö / Wikimedia Commons · CC BY 3.0

The government says the expanded cap could cut medicine prices by up to 70%, as the Supreme Court seeks a broader explanation.

Key takeaways

  • India has imposed a 30% trade-margin cap on 137 additional cancer drugs.
  • The Department of Pharmaceuticals expects the measure to cut prices by up to 70%.

India has imposed a 30% trade-margin cap on 137 more cancer drugs, with the lower prices due to take effect next month. The move followed Supreme Court scrutiny of mark-ups on the medicines.

The Department of Pharmaceuticals said the measure is expected to reduce prices by up to 70% and save patients 2,500 crore rupees a year. A 30% cap already applied to 42 drugs.

The Supreme Court has also asked the government why the cap should apply only to cancer medicines and not all non-patented drugs. It gave the government until 27 October to respond.

Topics
IndiaSupreme Court of India
Further reading

This article was produced with the help of AI technology. Based on reporting by the outlets listed above.

Comments (0)

Log in to join the discussion.Log in

No comments yet - be the first to weigh in.